CAH vs RNXT · P/E 35, rev $222.58B vs rev $266.0K
Cardinal Health Inc (CAH) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CAH and RNXT stock pages for the full models.
Not investment advice.